Literature DB >> 2018372

Increased effect of benzaldehyde by exchanging the hydrogen in the formyl group with deuterium.

E O Pettersen1, R O Larsen, B Børretzen, J M Dornish, R Oftebro.   

Abstract

The effect of benzaldehyde and various deuterated forms of benzaldehyde on human cells in culture has been investigated. While deuteration of the hydrogen atoms on the phenyl ring did not influence benzaldehyde's inactivating ability even after as long as 48 h treatment, deuteration of the formyl group resulted in a compound with a stronger inactivating effect than the nondeuterated benzaldehyde. Other cellular responses, such as inhibition of protein synthesis and of cell cycle progression, were also increased with benzaldehyde-d1 as compared to benzaldehyde. Since benzaldehyde is the basis for derivatives of chemotherapeutic interest, we suggest that the deuterated form of benzaldehyde in such derivatives will improve their clinical effects.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2018372

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  The bioavailability and dose dependency of the deuterated anti-tumour agent 4,6-benzylidene-d1-D-glucose in mice and rats.

Authors:  C B Dunsaed; J M Dornish; E O Pettersen
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

2.  Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).

Authors:  E O Pettersen; R O Larsen; J M Dornish; B Børretzen; M E Juul; T E Aastveit; J M Nesland; E K Rofstad; R Oftebro
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.